
0:00
NaN:NaN:NaN
A case in which the Court held that generic drug makers cannot be sued for not warning about potentially dangerous side effects on their drug labels, even when they follow federal rules that only require their labels to match those of their brand-name equivalents.
Więcej odcinków z kanału "U.S. Supreme Court 2010 Term Arguments"



Nie przegap odcinka z kanału “U.S. Supreme Court 2010 Term Arguments”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








